Allemagne


  • 7-juillet-2015

    Français

    Statistiques de l'OCDE sur la santé 2015 - Notes par pays

    Base de données Statistiques de l'OCDE sur la santé 2015 - Notes par pays

    Also AvailableEgalement disponible(s)
  • 3-December-2014

    English, PDF, 236kb

    Health at a Glance: Europe 2014 - Briefing Note for Germany

    Progress has been made to reduce smoking rates and alcohol consumption in Germany, but obesity is on the rise as in most other EU countries. As in other EU countries, spending for prevention in Germany accounts only for around 3% of current health spending.

    Related Documents
  • 5-novembre-2013

    Français

    Évaluer le coût humain de la crise : l'OCDE souligne combien il importe d’investir dans le bien-être

    Selon une nouvelle étude publiée par l'OCDE, la crise économique mondiale a eu d’importantes répercussions sur le bien-être des populations, qui s’étendent bien au-delà des suppressions d’emplois et de la perte de revenus puisqu’elles influent sur la satisfaction des individus à l’égard de leur vie et sur leur confiance dans les pouvoirs publics.

    Documents connexes
  • 22-October-2013

    English

    Managing Hospital Volumes: Germany and Experiences from OECD Countries

    To help inform the Conference on Managing Hospital Volumes, co-organised by the German Federal Ministry of Health and the OECD, and held on the 11th April 2013 in Berlin, the OECD Secretariat produced a paper to provide an international perspective on Germany’s situation and the current policy debate.

  • 24-avril-2012

    Français

    Santé : le coût élevé du diabète

    Quelque 83 millions de personnes sont atteintes de diabète dans l’ensemble des pays de l’OCDE. Compte tenu des tendances actuellement observées, ce sont près de 100 millions de personnes qui seront touchées par cette maladie à l’horizon 2030.

    Documents connexes
    Also AvailableEgalement disponible(s)
  • 20-April-2011

    English

    OECD Health Working Paper No. 56. Description of Alternative Approaches to Measure and Place a Value on Hospital Products in Seven OECD Countries

    To assess the feasibility of using secondary data sets information to feed an output-based PPP approach for hospital services, we reviewed the main characteristics of diagnoses and procedures coding standards, DRG classification systems, and cost-finding methods used in selected OECD countries.

  • 7-February-2011

    English

    OECD Health Working Paper No. 55: Mortality Amenable to Health Care in 31 OECD Countries: Estimates and Methodological Issues

    The mortality amenable to health care is defined as a possible indicator to measure the health care systems performance in preventing premature deaths that can be avoided by appropriate health care intervention. This paper assesses the feasibility of using this indicator in OECD countries.

    Related Documents
  • 27-October-2010

    English

    Workshop on Better Health through Bio-medicine: Innovative Governance

    For many of today’s new biomedical innovations, the distinctions between different forms of medical products such as drugs, diagnostics and devices no longer apply. Biomedicine also tends to realize its potential today through process innovation, even more than product innovation.

  • 21-October-2008

    English, , 771kb

    Pharmaceutical Pricing and Reimbursement Policies in Germany

    This paper (Health Working Paper No. 39) describes pharmaceutical pricing and reimbursement policies in Germany, considering them in the broader environment in which they operate, and assesses their impact on the achievement of a number of policy goals.

    Related Documents
  • 31-October-2006

    English

    Creation and Governance of Human Genetic Research Databases

    Summarises proceedings of a conference looking at examples of human genetic research databases, how they are established, how they are managed and governed, how they might be commercialised, and what the policy considerations might be.

  • 1 | 2 > >>